GlassScriptPhysician profile
Emily Gan
NPI 1699390237
$4,473.03
in general payments reported to CMS, 2019-2025
24 companies · $1,736 in 2025
The $1,736 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.13 · 2022: $1,948 · 2023: $13.96 · 2024: $735 · 2025: $1,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,384.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $737.36 | 2022-2025 | Tremfya |
| Abbvie INC. | $588.41 | 2022-2025 | |
| Leo Pharma INC. | $406.43 | 2022-2025 | Anzupgo, Adbry |
| Ucb, INC. | $333.06 | 2022-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $324.02 | 2022-2024 | |
| Lilly USA, LLC | $251.96 | 2022-2025 | Ebglyss, Taltz |
| Amgen INC. | $244.07 | 2021-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $229.51 | 2024-2025 | Nemluvio, Aklief |
| Pfizer INC. | $204.94 | 2022-2025 | |
| Incyte Corporation | $191.45 | 2022-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $180.54 | 2024-2025 | Cabtreo, Jublia |
| Regeneron Healthcare Solutions, INC. | $144.42 | 2022 | |
| Arcutis Biotherapeutics, INC. | $127.85 | 2024-2025 | Zoryve |
| Organon LLC | $115.25 | 2025 | Vtama |
| Genzyme Corporation | $83.40 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $67.28 | 2024-2025 | Xolair |
| Organogenesis INC. | $61.54 | 2024 | Novachor, Puraply Wound Matrix |
| Almirall LLC | $60.07 | 2024-2025 | Klisyri |
| Mission Pharmacal Company | $33.89 | 2021-2022 | |
| Journey Medical Corporation | $22.91 | 2025 | |
| Verrica Pharmaceuticals INC. | $18.11 | 2025 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.26 | 2024 | Spevigo |
| Medtronic, INC. | $15.34 | 2025 | Closurefast |
| E.R. Squibb & Sons, L.L.C. | $13.96 | 2023 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Gan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.